BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38362848)

  • 1. Comprehensive analysis of m
    Li H; Li C; Zhang Y; Jiang W; Zhang F; Tang X; Sun G; Xu S; Dong X; Shou J; Yang Y; Chen M
    Mol Carcinog; 2024 Apr; 63(4):677-687. PubMed ID: 38362848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability.
    Xu Y; Zhou J; Li L; Yang W; Zhang Z; Zhang K; Ma K; Xie H; Zhang Z; Cai L; Gong Y; Gong K
    Int J Biol Sci; 2022; 18(15):5943-5962. PubMed ID: 36263177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1α signalling axis.
    Zhuang C; Zhuang C; Luo X; Huang X; Yao L; Li J; Li Y; Xiong T; Ye J; Zhang F; Gui Y
    J Cell Mol Med; 2019 Mar; 23(3):2163-2173. PubMed ID: 30648791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The m
    He Y; Chen Y; Li Z; Wu C
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):30. PubMed ID: 38270643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m
    Chen Y; Zhou C; Sun Y; He X; Xue D
    Epigenomics; 2020 Jan; 12(2):87-99. PubMed ID: 31856595
    [No Abstract]   [Full Text] [Related]  

  • 6. MiR-155 regulates m
    Yang W; Xie L; Wang P; Zhuang C
    Cell Signal; 2022 Mar; 91():110217. PubMed ID: 34921979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N
    Zhang Y; Yao Y; Qi X; Li J; Liu M; Che X; Xu Y; Wu G
    J Immunol Res; 2021; 2021():6617841. PubMed ID: 33628845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between RNA Methylation Eraser FTO and Writer METTL3 in Renal Clear Cell Carcinoma Patient Survival.
    Zhao J; Lu L
    Recent Pat Anticancer Drug Discov; 2021; 16(3):363-376. PubMed ID: 33563180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
    Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
    J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
    Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
    J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N
    von Hagen F; Gundert L; Strick A; Klümper N; Schmidt D; Kristiansen G; Tolkach Y; Toma M; Ritter M; Ellinger J
    Mol Carcinog; 2021 May; 60(5):354-362. PubMed ID: 33755994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.
    Mehdi A; Riazalhosseini Y
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28812986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N
    Strick A; von Hagen F; Gundert L; Klümper N; Tolkach Y; Schmidt D; Kristiansen G; Toma M; Ritter M; Ellinger J
    BJU Int; 2020 Apr; 125(4):617-624. PubMed ID: 31985880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular subtypes of m
    Guan B; Ren F; Shan W; Zhang S
    Transl Cancer Res; 2022 Mar; 11(3):508-518. PubMed ID: 35402182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of gene expression on survival of clear cell renal cell carcinoma.
    Berglund A; Amankwah EK; Kim YC; Spiess PE; Sexton WJ; Manley B; Park HY; Wang L; Chahoud J; Chakrabarti R; Yeo CD; Luu HN; Pietro GD; Parker A; Park JY
    Cancer Med; 2020 Nov; 9(22):8662-8675. PubMed ID: 32986937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma.
    Fang Y; Chen G; Chen F; Hu E; Dong X; Li Z; He L; Sun Y; Qiu L; Xu H; Cai Z; Liu X
    Cancer Sci; 2021 Sep; 112(9):3555-3568. PubMed ID: 34255396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary Study of Whole-Genome Bisulfite Sequencing and Transcriptome Sequencing in VHL Disease-Associated ccRCC.
    Li L; Bao H; Xu Y; Yang W; Zhang Z; Ma K; Zhang K; Zhou J; Gong Y; Ci W; Gong K
    Mol Diagn Ther; 2023 Nov; 27(6):741-752. PubMed ID: 37587253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The m
    Xiao Y; Thakkar KN; Zhao H; Broughton J; Li Y; Seoane JA; Diep AN; Metzner TJ; von Eyben R; Dill DL; Brooks JD; Curtis C; Leppert JT; Ye J; Peehl DM; Giaccia AJ; Sinha S; Rankin EB
    Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21441-21449. PubMed ID: 32817424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
    Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
    J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.
    Zhang X; Hao H; Ma L; Zhang Y; Hu X; Chen Z; Liu D; Yuan J; Hu Z; Guan W
    mBio; 2021 Aug; 12(4):e0106721. PubMed ID: 34225491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.